NASDAQ:VIR

Vir Biotechnology Stock Forecast

etoro logo Buy VIR
*Your capital is at risk
$9.57
+0.410 (+4.48%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of VIR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add VIR to Watchlist?
Some Reasons Why To Add VIR:
  • High gross margin of 275.2%
  • +89.5% price growth over the last year
  • +61.1% YTD performance
PDF

Stronger technical forecast for Vir Biotechnology, Inc. stock price after Monday trading
(Updated on Jun 22, 2026)

Buy or Hold candidate since Jun 17, 2026 Gain 2.90%

The Vir Biotechnology, Inc. stock price gained 4.48% on the last trading day (Monday, 22nd Jun 2026), rising from $9.16 to $9.57. During the last trading day the stock fluctuated 5.13% from a day low at $9.16 to a day high of $9.63. The price has risen in 5 of the last 10 days and is up by 10.64% over the past 2 weeks. Volume fell on the last day by -4 million shares and in total, 2 million shares were bought and sold for approximately $16.61 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.37% during the next 3 months and, with a 90% probability hold a price between $7.65 and $9.92 at the end of this 3-month period.

VIR Signals & Forecast

Mostly positive signals in the chart today. The Vir Biotechnology, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $8.91 and $9.10. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 16.00%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Vir Biotechnology, Inc. stock

Vir Biotechnology, Inc. finds support from accumulated volume at $9.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.470 between high and low, or 5.13%. For the last week, the stock has had daily average volatility of 5.71%.

Our recommended stop-loss: $9.25 (-3.34%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (VIR) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Vir Biotechnology, Inc. to open at $9.45, and during the day (based on 14 day Average True Range), to move between $9.33 and $9.81, which gives a possible trading interval of +/-$0.478 (+/-5.13%) up or down from last closing price. If Vir Biotechnology, Inc. takes out the full calculated possible swing range there will be an estimated 5.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $9.16 (4.28%) than the resistance at $10.05 (5.02%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vir Biotechnology, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 4.258 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $9.45 ( 1.22%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

VIR Performance

Trading levels for VIR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.92 3.69%
R2 9.74 1.82%
R1 9.63 0.657%
Price 9.57
S1 9.27 -3.10%
S2 9.16 -4.25%
S3 8.98 -6.13%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.09 15.88%
R2 10.67 11.49%
R1 10.05 5.02%
Price 9.57
S1 9.16 -4.28%
S2 8.96 -6.37%
S3 8.61 -10.03%

FAQ

What is the symbol for Vir Biotechnology, Inc. Stock and on which exchange is it traded?
The symbol for Vir Biotechnology, Inc. is VIR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vir Biotechnology, Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Vir Biotechnology, Inc. Stock?
Vir Biotechnology, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vir Biotechnology, Inc. Stock.

What's the current price of Vir Biotechnology, Inc. Stock?
As of the end of day on the Jun 22, 2026, the price of an Vir Biotechnology, Inc. (VIR) share was $9.57.

What is the 52-week high and low for Vir Biotechnology, Inc. Stock?
The 52-week high for Vir Biotechnology, Inc. Stock is $11.66 and the 52-week low is $4.16.

What is the market capitalization of Vir Biotechnology, Inc. Stock?
As of the Jun 22, 2026, the market capitalization of Vir Biotechnology, Inc. is 1.614B.

When is the next earnings date for Vir Biotechnology, Inc.?
The upcoming earnings date for Vir Biotechnology, Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT VIR BIOTECHNOLOGY, INC.
Vir Biotechnology
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus....
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE